Therapeutic innovations in breast cancer.
La Presse Médicale（2019）
摘要
Managing endocrine resistance and resistance to endocrine therapy for ER+ HER2− breast cancer with the CDK 4/6 inhibitors in the metastatic setting.
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要